| Writing Group Member | Employment | Research Grant | Other Research Support |
Speakers’ Bureau/Honoraria |
Expert Witness | Ownership Interest |
Consultant/Advisory Board |
Other |
|---|---|---|---|---|---|---|---|---|
| Véronique L. Roger | Mayo Clinic | None | None | None | None | None | None | None |
| Robert J. Adams | Medical University of South Carolina | NHLBI† | None | Boehringer Ingelheim†; Genentech* | None | None | Boehringer Ingelheim†; Novartis* | None |
| Jarett D. Berry | UT Southwestern Medical School | AHA†; NHLBI† | None | Merck† | None | None | None | None |
| Todd M. Brown | University of Alabama at Birmingham | NIH† | None | None | None | None | None | None |
| Mercedes R. Carnethon | Northwestern University | None | None | None | None | None | None | None |
| Shifan Dai | Centers for Disease Control and Prevention | None | None | None | None | None | None | None |
| Giovanni de Simone | Federico II University of Naples | None | None | None | None | None | None | None |
| Earl S. Ford | Centers for Disease Control and Prevention | None | None | None | None | None | None | None |
| Caroline S. Fox | NHLBI | None | None | None | None | None | None | None |
| Heather J. Fullerton | University of California, San Francisco | None | None | None | None | None | None | None |
| Cathleen Gillespie | Centers for Disease Control and Prevention | None | None | None | None | None | None | None |
| Alan S. Go | The Permanente Medical Group | Johnson & Johnson†; GlaxoSmithKline† | None | None | None | None | None | None |
| Kurt J. Greenlund | Centers for Disease Control and Prevention | None | None | None | None | None | None | None |
| Susan M. Hailpern | Northern Westchester Hospital | None | None | None | None | None | None | None |
| John A. Heit | Mayo Clinic | None | None | None | None | None | None | None |
| P. Michael Ho | Denver VA Medical Center | None | None | None | None | None | Wellpoint Inc.* | None |
| Virginia J. Howard | University of Alabama at Birmingham | NIH/NINDS† | None | None | None | None | None | None |
| Brett M. Kissela | University of Cincinnati | NIH/NCRR†; NIH/NINDS† | None | None | Expert witness for defense in 1 stroke-related case in 2010† | None | Allergan† | None |
| Steven J. Kittner | University of Maryland School of Medicine | None | None | None | None | None | None | None |
| Daniel T. Lackland | Medical University of South Carolina | None | None | None | None | None | None | None |
| Judith H. Lichtman | Yale School of Medicine | None | None | None | None | None | None | None |
| Lynda D. Lisabeth | University of Michigan | None | None | None | None | None | None | None |
| Donald M. Lloyd-Jones | Northwestern | None | None | None | None | None | None | None |
| Diane M. Makuc | National Center for Health Statistics, CDC | None | None | None | None | None | None | None |
| Gregory M. Marcus | UCSF | None | None | None | None | None | None | None |
| Ariane Marelli | McGill University Health Center | None | None | None | None | None | None | None |
| David B. Matchar | Duke-NUS Graduate Medical School | None | None | None | None | None | Boehringer Ingelheim* | None |
| Mary M. McDermott | Northwestern University’s Feinberg School of Medicine | None | None | None | None | None | None | Contributing Editor for JAMA |
| James B. Meigs | Massachusetts General Hospital | None | None | None | None | None | None | None |
| Claudia S. Moy | National Institutes of Health | None | None | None | None | None | None | None |
| Dariush Mozaffarian | Harvard School of Public Health | NIH†; Harvard†; Gates Foundation/World Health Organization†; Searle Funds at the Chicago Community Trust† | None | Aramark*; International Life Sciences Institute*; SPRIM*; Unilvever*; US Food and Drug Administration*; World Health Organization* | None | Royalties from UpToDate for an online chapter* | Nutrition Impact*` | None |
| Michael E. Mussolino | National Heart, Lung, and Blood Institute | None | None | None | None | None | None | None |
| Graham Nichol | University of Washington | Asmund S Laerdal Foundation for Acute Medicine†; Medtronic Inc. †; NHLBI†; NIH† | None | None | None | None | Gambro Renal Inc*; Lifebridge Medizintechnik AG*; Sotera Wireless* | None |
| Nina P. Paynter | Brigham and Women’s Hospital | F. Hoffman LaRoche Ltd. † | None | None | None | None | None | None |
| Wayne D. Rosamond | University of North Carolina | None | None | None | None | None | None | None |
| Paul D. Sorlie | National Heat, Lung and Blood Institute, NIH | None | None | None | None | None | None | None |
| Randall S. Stafford | Stanford University | None | None | None | None | None | None | None |
| Tanya N. Turan | Medical University of South Carolina | Applied Clinical Intelligence*; NIH/NINDS† | None | None | None | None | None | AAN Clinical Research Fellowship† |
| Melanie B. Turner | American Heart Association | None | None | None | None | None | None | None |
| Nathan D. Wong | University of California, Irvine | Bristol-Myers Squibb†; Forest†; Novartis Pharmaceuticals† | None | None | None | None | None | None |
| Judith Wylie-Rosett | Albert Einstein College of Medicine | Kraft via subcontract from Provident* | None | None | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.
†
Significant.